Oxytocics for the prevention of post-partum haemorrhages. A review
- PMID: 1795933
- DOI: 10.1007/BF02015577
Oxytocics for the prevention of post-partum haemorrhages. A review
Abstract
Secale alkaloids, oxytocin and prostaglandins are used to prevent post-partum haemorrhage (post-partum haemorrhage defined as blood loss greater than or equal to 500 ml). Any oxytocic drug administered in the third stage of labour reduces the blood loss with approximately 40% and hence the incidence of post-partum haemorrhage from 10 to 6%. Therefore, routine active management of the third stage with an oxytocic drug is strongly advocated. Because of the fewest side-effects oxytocin is regarded as the best drug available at this moment.
Similar articles
-
A prospective cohort study evaluating the cost-effectiveness of carbetocin for prevention of postpartum haemorrhage in caesarean sections.J Obstet Gynaecol. 2017 Jul;37(5):601-604. doi: 10.1080/01443615.2017.1284188. Epub 2017 Mar 20. J Obstet Gynaecol. 2017. PMID: 28317421
-
The prevention of post partum haemorrhage: optimising routine management of the third stage of labour.Eur J Obstet Gynecol Reprod Biol. 1996 Oct;69(1):19-24. doi: 10.1016/0301-2115(95)02529-4. Eur J Obstet Gynecol Reprod Biol. 1996. PMID: 8909952 Review.
-
Prevention of postpartum haemorrhage.Baillieres Clin Obstet Gynaecol. 1995 Sep;9(3):619-31. doi: 10.1016/s0950-3552(05)80385-2. Baillieres Clin Obstet Gynaecol. 1995. PMID: 8846560 Review.
-
Choice of oxytocic preparation for routine use in the management of the third stage of labour: an overview of the evidence from controlled trials.Br J Obstet Gynaecol. 1988 Jan;95(1):17-30. doi: 10.1111/j.1471-0528.1988.tb06476.x. Br J Obstet Gynaecol. 1988. PMID: 3277662 Review.
-
A randomised placebo controlled trial of oral misoprostol in the third stage of labour.Br J Obstet Gynaecol. 1998 Sep;105(9):971-5. doi: 10.1111/j.1471-0528.1998.tb10259.x. Br J Obstet Gynaecol. 1998. PMID: 9763047 Clinical Trial.
Cited by
-
Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology.Drugs. 1998 Oct;56(4):523-35. doi: 10.2165/00003495-199856040-00002. Drugs. 1998. PMID: 9806101 Review.
-
Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions.ACS Omega. 2021 Feb 15;6(8):5805-5811. doi: 10.1021/acsomega.0c06248. eCollection 2021 Mar 2. ACS Omega. 2021. PMID: 33681619 Free PMC article.
-
Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products.Pharm Res. 2009 Jul;26(7):1679-88. doi: 10.1007/s11095-009-9878-2. Epub 2009 Apr 3. Pharm Res. 2009. PMID: 19343484 Free PMC article.
-
Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.AAPS J. 2015 Jan;17(1):144-55. doi: 10.1208/s12248-014-9688-2. Epub 2014 Nov 15. AAPS J. 2015. PMID: 25398427 Free PMC article. Review.